Svastia
500 GlobalSan Francisco, GB · Founded 2019 · 1 employees on LinkedIn · 1 known investors
Find your way into Svastia
Sign up to see every warm intro you have to Svastia
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Svastia team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Svastia is a clinical-genomic platform that uses genetic screening to improve cancer therapy outcomes for pharmaceutical companies and hospitals. The platform bundles contract research services with bioinformatics analysis, and coordinates a distributed network of laboratory service providers to support drug development, clinical trial patient selection, and personalized treatment recommendations.
Founders & leadership
Svastia was founded in 2019 by Balamurali Rathinam and Parthiban Vijayarangakannan.

Investors · 1
How we know: open dataset · 500 Global portfolio 2026-08 · Not right? Tell us
Frequently asked questions
- What does Svastia do?
- Svastia is a clinical-genomic platform that uses genetic screening to improve cancer therapy outcomes for pharmaceutical companies and hospitals. The platform bundles contract research services with bioinformatics analysis, and coordinates a distributed network of laboratory service providers to support drug development, clinical trial patient selection, and personalized treatment recommendations.
- Who founded Svastia?
- Svastia was founded by Balamurali Rathinam, Parthiban Vijayarangakannan in 2019.
- Who are Svastia's investors?
- Svastia's investors include 500 Global.
- Where is Svastia headquartered?
- Svastia is headquartered in San Francisco, GB.

